Inflammation, fatigue tied to omega-3 intake after breast cancer

March 13, 2012
Inflammation, fatigue tied to omega-3 intake after breast CA

(HealthDay) -- For breast cancer survivors there may be an association between inflammation, intake of omega-3 polyunsaturated fatty acid (PUFA), and fatigue, with increased intake linked to decreased inflammation and fatigue, according to research published online March 12 in the Journal of Clinical Oncology.

Catherine M. Alfano, Ph.D., of the in Bethesda, Md., and colleagues conducted a study involving 633 breast cancer survivors who participated in the Health, Eating, Activity, and Lifestyle Study; provided blood samples 30 months after diagnosis; and completed the Piper Fatigue Scale and Short Form-36 vitality scale 39 months after diagnosis. Blood samples were analyzed for C-reactive protein (CRP) and serum amyloid A levels.

The researchers found that, as CRP increased, behavioral and sensory fatigue scale scores increased, but the association was attenuated after adjustment for comorbidity and medication use. After full adjustment, breast cancer survivors with high were 1.8-fold more likely to experience fatigue. Those who had higher intake of omega-6 compared with omega-3 had higher CRP levels and were more likely to experience fatigue (odds ratio for highest versus lowest intake, 2.6).

"If confirmed by other studies, these results point toward a future trial testing whether omega-3 PUFA supplements may reduce inflammation among and whether they may also reduce fatigue, especially , among those suffering most from this potentially debilitating condition. Considering the high prevalence of fatigue among cancer survivors, effective treatment could have a significant health impact," the authors write.

Several authors disclosed financial ties to the pharmaceutical, biotechnology, and nutritional supplement industries.

Explore further: Sleep issues contribute to cognitive problems in childhood cancer survivors

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.